Icatibant, a selective bradykinin B2 receptor antagonist, effective and safe in treating the symptoms of hereditary angioedema (HAE) attacks

被引：4
|
作者：
Riedl, M. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2008年 / 121卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2007.12.411
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
398
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [41] The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED
    Bartal, Carmi
    Zeldetz, Vladimir
    Stavi, Vered
    Barski, Leonid
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015, 33 (03): : 479.e1 - 479.e3
  • [42] A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant
    M Bas
    J Greve
    G Kojda
    H Bier
    T Hoffmann
    Critical Care, 10 (Suppl 1):
  • [43] Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems
    Charignon, Delphine
    Spaeth, Peter
    Martin, Ludovic
    Drouet, Christian
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2233 - 2247
  • [44] Icatibant acetate -: Treatment of hereditary angioedema -: Agent for liver cirrhosis -: Antiasthmatic drug -: Treatment of osteoarthritis pain -: Bradykinin B2 antagonist
    Sorbera, LA
    Fernández-Forner, D
    Bayés, M
    DRUGS OF THE FUTURE, 2006, 31 (02) : 101 - 106
  • [45] Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study
    Campos, Regis Albuquerque
    Rodrigues Valle, Solange Oliveira
    Franca, Alfeu Tavares
    Cordeiro, Elisabete
    Serpa, Faradiba Sarquis
    Mello, Yara Ferreira
    Malheiros, Teresinha
    Toledo, Eliana
    Mansour, Elie
    Fusaro, Gustavo
    Grumach, Anete Sevciovic
    SAO PAULO MEDICAL JOURNAL, 2014, 132 (05): : 261 - 265
  • [46] Treatment of idiopathic angio-edema with Icatibant, a bradykinin B2 receptor antagonist
    Bork, K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 177 - 177
  • [47] BRADYKININ B2 RECEPTOR ANTAGONIST OFF LABEL USE IN SHORT-TERM PROPHYLAXIS IN HEREDITARY ANGIOEDEMA
    Angeletti, C.
    Angeletti, P. M.
    Mastrobuono, F.
    Pilotti, L.
    Ciccozzi, A.
    Guetti, C.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2014, 27 (04) : 653 - 659
  • [48] Icatibant, a Selective Bradykinin-B2 Receptor Antagonist, in Acquired Angioedema Due to C1 Inhibitor Deficiency
    Bork, K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB100 - AB100
  • [49] Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant
    Weller, K.
    Magerl, M.
    Maurer, M.
    ALLERGY, 2009, 64 : 155 - 156
  • [50] Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant
    Weller, K.
    Magerl, M.
    Maurer, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (01) : 120 - 120
12345